Cargando…

Mortality as an indicator of quality of neurosurgical care in England: a retrospective cohort study

OBJECTIVES: Postoperative mortality is a widely used quality indicator, but it may be unreliable when procedure numbers and/or mortality rates are low, due to insufficient statistical power. The objective was to investigate the statistical validity of postoperative 30-day mortality as a quality metr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahba, Adam J, Cromwell, David A, Hutchinson, Peter J, Mathew, Ryan K, Phillips, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639111/
https://www.ncbi.nlm.nih.gov/pubmed/36332948
http://dx.doi.org/10.1136/bmjopen-2022-067409
_version_ 1784825568469975040
author Wahba, Adam J
Cromwell, David A
Hutchinson, Peter J
Mathew, Ryan K
Phillips, Nick
author_facet Wahba, Adam J
Cromwell, David A
Hutchinson, Peter J
Mathew, Ryan K
Phillips, Nick
author_sort Wahba, Adam J
collection PubMed
description OBJECTIVES: Postoperative mortality is a widely used quality indicator, but it may be unreliable when procedure numbers and/or mortality rates are low, due to insufficient statistical power. The objective was to investigate the statistical validity of postoperative 30-day mortality as a quality metric for neurosurgical practice across healthcare providers. DESIGN: Retrospective cohort study. SETTING: Hospital Episode Statistics data from all neurosurgical units in England. PARTICIPANTS: Patients who underwent neurosurgical procedures between April 2013 and March 2018. Procedures were grouped using the National Neurosurgical Audit Programme classification. OUTCOMES MEASURED: National 30-day postoperative mortality rates were calculated for elective and non-elective neurosurgical procedural groups. The study estimated the proportion of neurosurgeons and NHS trusts in England that performed sufficient procedures in 3-year and 5-year periods to detect unusual performance (defined as double the national rate of mortality). The actual difference in mortality rates that could be reliably detected based on procedure volumes of neurosurgeons and units over a 5-year period was modelled. RESULTS: The 30-day mortality rates for all elective and non-elective procedures were 0.4% and 6.1%, respectively. Only one neurosurgeon in England achieved the minimum sample size (n=2402) of elective cases in 5 years needed to detect if their mortality rate was double the national average. All neurosurgical units achieved the minimum sample sizes for both elective (n=2402) and non-elective (n=149) procedures. In several neurosurgical subspecialties, approximately 80% of units (or more) achieved the minimum sample sizes needed to detect if their mortality rate was double the national rate, including elective neuro-oncology (baseline mortality rate=2.3%), non-elective neuro-oncology (rate=5.7%), neurovascular (rate=6.7%) and trauma (rate=11%). CONCLUSION: Postoperative mortality lacks statistical power as a measure of individual neurosurgeon performance. Neurosurgical units in England performed sufficient procedure numbers overall and in several subspecialty areas to support the use of mortality as a quality indicator.
format Online
Article
Text
id pubmed-9639111
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96391112022-11-08 Mortality as an indicator of quality of neurosurgical care in England: a retrospective cohort study Wahba, Adam J Cromwell, David A Hutchinson, Peter J Mathew, Ryan K Phillips, Nick BMJ Open Health Services Research OBJECTIVES: Postoperative mortality is a widely used quality indicator, but it may be unreliable when procedure numbers and/or mortality rates are low, due to insufficient statistical power. The objective was to investigate the statistical validity of postoperative 30-day mortality as a quality metric for neurosurgical practice across healthcare providers. DESIGN: Retrospective cohort study. SETTING: Hospital Episode Statistics data from all neurosurgical units in England. PARTICIPANTS: Patients who underwent neurosurgical procedures between April 2013 and March 2018. Procedures were grouped using the National Neurosurgical Audit Programme classification. OUTCOMES MEASURED: National 30-day postoperative mortality rates were calculated for elective and non-elective neurosurgical procedural groups. The study estimated the proportion of neurosurgeons and NHS trusts in England that performed sufficient procedures in 3-year and 5-year periods to detect unusual performance (defined as double the national rate of mortality). The actual difference in mortality rates that could be reliably detected based on procedure volumes of neurosurgeons and units over a 5-year period was modelled. RESULTS: The 30-day mortality rates for all elective and non-elective procedures were 0.4% and 6.1%, respectively. Only one neurosurgeon in England achieved the minimum sample size (n=2402) of elective cases in 5 years needed to detect if their mortality rate was double the national average. All neurosurgical units achieved the minimum sample sizes for both elective (n=2402) and non-elective (n=149) procedures. In several neurosurgical subspecialties, approximately 80% of units (or more) achieved the minimum sample sizes needed to detect if their mortality rate was double the national rate, including elective neuro-oncology (baseline mortality rate=2.3%), non-elective neuro-oncology (rate=5.7%), neurovascular (rate=6.7%) and trauma (rate=11%). CONCLUSION: Postoperative mortality lacks statistical power as a measure of individual neurosurgeon performance. Neurosurgical units in England performed sufficient procedure numbers overall and in several subspecialty areas to support the use of mortality as a quality indicator. BMJ Publishing Group 2022-11-04 /pmc/articles/PMC9639111/ /pubmed/36332948 http://dx.doi.org/10.1136/bmjopen-2022-067409 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Health Services Research
Wahba, Adam J
Cromwell, David A
Hutchinson, Peter J
Mathew, Ryan K
Phillips, Nick
Mortality as an indicator of quality of neurosurgical care in England: a retrospective cohort study
title Mortality as an indicator of quality of neurosurgical care in England: a retrospective cohort study
title_full Mortality as an indicator of quality of neurosurgical care in England: a retrospective cohort study
title_fullStr Mortality as an indicator of quality of neurosurgical care in England: a retrospective cohort study
title_full_unstemmed Mortality as an indicator of quality of neurosurgical care in England: a retrospective cohort study
title_short Mortality as an indicator of quality of neurosurgical care in England: a retrospective cohort study
title_sort mortality as an indicator of quality of neurosurgical care in england: a retrospective cohort study
topic Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639111/
https://www.ncbi.nlm.nih.gov/pubmed/36332948
http://dx.doi.org/10.1136/bmjopen-2022-067409
work_keys_str_mv AT wahbaadamj mortalityasanindicatorofqualityofneurosurgicalcareinenglandaretrospectivecohortstudy
AT cromwelldavida mortalityasanindicatorofqualityofneurosurgicalcareinenglandaretrospectivecohortstudy
AT hutchinsonpeterj mortalityasanindicatorofqualityofneurosurgicalcareinenglandaretrospectivecohortstudy
AT mathewryank mortalityasanindicatorofqualityofneurosurgicalcareinenglandaretrospectivecohortstudy
AT phillipsnick mortalityasanindicatorofqualityofneurosurgicalcareinenglandaretrospectivecohortstudy